Post-stroke cognitive impairment and dementia

NS Rost, A Brodtmann, MP Pase, SJ van Veluw… - Circulation …, 2022 - Am Heart Assoc
Poststroke cognitive impairment and dementia (PSCID) is a major source of morbidity and
mortality after stroke worldwide. PSCID occurs as a consequence of ischemic stroke …

Molecular biomarkers for vascular cognitive impairment and dementia

S Hosoki, GK Hansra, T Jayasena, A Poljak… - Nature Reviews …, 2023 - nature.com
As disease-specific interventions for dementia are being developed, the ability to identify the
underlying pathology and dementia subtypes is increasingly important. Vascular cognitive …

Cognitive impairment and dementia after stroke: design and rationale for the DISCOVERY study

NS Rost, JF Meschia, R Gottesman, L Wruck, K Helmer… - Stroke, 2021 - Am Heart Assoc
Stroke is a leading cause of the adult disability epidemic in the United States, with a major
contribution from poststroke cognitive impairment and dementia (PSCID), the rates of which …

Cardiovascular comorbidities, inflammation, and cerebral small vessel disease

LE Evans, JL Taylor, CJ Smith… - Cardiovascular …, 2021 - academic.oup.com
Cerebral small vessel disease (cSVD) is the most common cause of vascular cognitive
impairment and affects all levels of the brain's vasculature. Features include diverse …

The complex pathway between amyloid β and cognition: implications for therapy

WJ Jagust, CE Teunissen, C DeCarli - The Lancet Neurology, 2023 - thelancet.com
For decades, the hypothesis that brain deposition of the amyloid β protein initiates
Alzheimer's disease has dominated research and clinical trials. Targeting amyloid β is …

The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis

M Morrens, C Overloop, V Coppens, E Loots… - Molecular …, 2022 - nature.com
Background In psychotic and mood disorders, immune alterations are hypothesized to
underlie cognitive symptoms, as they have been associated with elevated blood levels of …

MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols

D Wilcock, G Jicha, D Blacker, MS Albert… - Alzheimer's & …, 2021 - Wiley Online Library
The concept of vascular contributions to cognitive impairment and dementia (VCID) derives
from more than two decades of research indicating that (1) most older individuals with …

Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study

DD Zhang, Y Cao, JY Mu, YM Liu, F Gao… - Stroke and Vascular …, 2022 - svn.bmj.com
Background and purpose Although inflammation has been proposed to be a candidate risk
factor for cerebral small vessel disease (CSVD), previous findings remain largely …

Instrumental validation of free water, peak‐width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kits

P Maillard, H Lu, K Arfanakis, BT Gold… - Alzheimer's & …, 2022 - Wiley Online Library
Introduction To describe the protocol and findings of the instrumental validation of three
imaging‐based biomarker kits selected by the MarkVCID consortium: free water (FW) and …

Placental growth factor as a sensitive biomarker for vascular cognitive impairment

JD Hinman, F Elahi, D Chong… - Alzheimer's & …, 2023 - Wiley Online Library
INTRODUCTION High‐performing biomarkers measuring the vascular contributions to
cognitive impairment and dementia are lacking. METHODS Using a multi‐site observational …